Envestnet Asset Management Inc. Has $30.09 Million Stake in Integer Holdings Co. (NYSE:ITGR)

Envestnet Asset Management Inc. grew its position in shares of Integer Holdings Co. (NYSE:ITGR) by 0.8% in the 2nd quarter, Holdings Channel reports. The institutional investor owned 259,830 shares of the medical equipment provider’s stock after acquiring an additional 1,941 shares during the period. Envestnet Asset Management Inc.’s holdings in Integer were worth $30,086,000 as of its most recent SEC filing.

Several other institutional investors have also made changes to their positions in the company. Westover Capital Advisors LLC lifted its holdings in shares of Integer by 18.2% during the 2nd quarter. Westover Capital Advisors LLC now owns 2,704 shares of the medical equipment provider’s stock valued at $313,000 after buying an additional 417 shares during the last quarter. Zions Bancorporation N.A. boosted its position in Integer by 4.6% during the second quarter. Zions Bancorporation N.A. now owns 22,084 shares of the medical equipment provider’s stock worth $2,557,000 after purchasing an additional 964 shares during the period. American Century Companies Inc. boosted its position in Integer by 249.7% during the second quarter. American Century Companies Inc. now owns 15,710 shares of the medical equipment provider’s stock worth $1,819,000 after purchasing an additional 11,218 shares during the period. Quest Partners LLC boosted its position in Integer by 3,688.9% during the second quarter. Quest Partners LLC now owns 341 shares of the medical equipment provider’s stock worth $39,000 after purchasing an additional 332 shares during the period. Finally, Great Lakes Advisors LLC boosted its position in Integer by 56.7% during the second quarter. Great Lakes Advisors LLC now owns 45,218 shares of the medical equipment provider’s stock worth $5,236,000 after purchasing an additional 16,355 shares during the period. 99.29% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, Director Jean M. Hobby sold 11,960 shares of the stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $119.66, for a total value of $1,431,133.60. Following the completion of the transaction, the director now owns 2,280 shares in the company, valued at approximately $272,824.80. The sale was disclosed in a filing with the SEC, which is available at this link. 2.00% of the stock is owned by company insiders.

Integer Stock Down 1.7 %

Shares of ITGR stock opened at $129.19 on Friday. Integer Holdings Co. has a 12 month low of $69.40 and a 12 month high of $131.87. The firm has a market cap of $4.33 billion, a PE ratio of 44.70, a price-to-earnings-growth ratio of 1.81 and a beta of 1.09. The stock has a 50 day moving average of $122.98 and a 200-day moving average of $118.60. The company has a quick ratio of 1.96, a current ratio of 3.29 and a debt-to-equity ratio of 0.73.

Integer (NYSE:ITGR) last issued its quarterly earnings results on Thursday, July 25th. The medical equipment provider reported $1.30 EPS for the quarter, topping analysts’ consensus estimates of $1.24 by $0.06. Integer had a return on equity of 11.48% and a net margin of 6.31%. The company had revenue of $436.20 million during the quarter, compared to analyst estimates of $437.00 million. During the same period in the previous year, the company earned $1.14 earnings per share. The company’s quarterly revenue was up 9.0% compared to the same quarter last year. On average, equities analysts predict that Integer Holdings Co. will post 5.31 EPS for the current year.

Analysts Set New Price Targets

ITGR has been the subject of a number of recent analyst reports. Benchmark reaffirmed a “buy” rating and set a $130.00 target price on shares of Integer in a research report on Friday, August 2nd. Oppenheimer initiated coverage on Integer in a research report on Tuesday, July 16th. They set an “outperform” rating and a $135.00 target price for the company. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat, Integer currently has a consensus rating of “Moderate Buy” and a consensus target price of $133.86.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.